BNXT — BioNxt Solutions Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for BioNxt Solutions, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	2.58	1.35	0.136	0.364	0.032
Net Total Accounts Receivable
Net Total Receivables	0.306	0.546	0.459	0.283	0.061
Total Inventory
Prepaid Expenses
Total Current Assets	3.03	2.7	0.691	0.719	0.164
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5.24	1.13	0.921	0.549	0.406
Net Goodwill
Net Intangible Assets
Total Assets	8.28	9.73	1.61	1.27	0.569
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.47	5.45	2.02	6.55	6.88
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Liabilities	4.28	8.06	5.74	6.55	8.43
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	4.01	1.67	-4.13	-5.28	-7.86
Total Liabilities & Shareholders' Equity	8.28	9.73	1.61	1.27	0.569
Total Common Shares Outstanding